The API5 Knockout HAP1 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout population of the human HAP1 cell line, harboring a targeted disruption of the API5 gene. This pooled knockout model provides a powerful tool for functional loss-of-function studies without clonal selection, enabling robust population-level analyses of apoptosis regulation and survival signaling. The polyclonal format preserves genetic diversity while ensuring efficient ablation of API5 protein expression. Researchers can utilize this knockout resource to dissect the role of API5 in modulating programmed cell death and to explore its impact on cellular response to apoptotic stimuli.
HAP1 cells are a near-haploid human cell line derived from the KBM-7 chronic myeloid leukemia model, extensively characterized for their utility in haploid genetic screens and functional genomics. The haploid karyotype simplifies gene knockout and phenotype-genotype correlations, making HAP1 an ideal chassis for CRISPR-based perturbations. Their adherent growth and rapid doubling time facilitate high-throughput assays, and the leukemic origin provides a clinically relevant background for studying oncogenic signaling and drug resistance. The combination of API5 disruption and the HAP1 genetic context offers a unique platform to investigate apoptosis inhibition in a malignant setting.
API5 (Apoptosis Inhibitor 5, also known as AAC-11) is a key suppressor of apoptosis that directly interacts with and inhibits caspase-3 activation, blocking the execution phase of apoptosis. It also associates with Acinus, a factor involved in chromatin condensation. API5 is transcriptionally regulated by E2F1 and NF-??B in response to cytokines and survival signals. Downstream, it controls caspase-3, caspase-7, and Bcl-2 family proteins, placing it at a central junction in survival and TNF signaling. Disruption of API5 in HAP1 cells abrogates this anti-apoptotic function, rendering cells more susceptible to death stimuli.
In the HAP1 haploid background, loss of API5 provides a clean genetic system to study apoptosis resistance mechanisms relevant to cancer. Given that API5 overexpression is associated with chemotherapy resistance in multiple tumors, these knockout cells allow precise dissection of drug-induced apoptosis pathways. The near-haploid state eliminates functional redundancy from diploid alleles, making phenotypic effects more pronounced and enabling clear interpretation of results from genetic screens. This is particularly valuable for synthetic lethality studies aiming to identify targets that can circumvent apoptosis evasion in cancer.
Typical applications include investigating apoptotic execution mechanisms via caspase activity assays, Annexin V staining, and cell viability measurements following treatment with chemotherapeutics or TNF ligands. Western blot analysis of API5 and cleaved caspase-3 validates pathway engagement. Use in functional genomics screens can identify cooperating factors. These cells also serve as a platform for high-throughput drug screening to identify compounds that selectively target API5-dependent survival mechanisms. For assistance with experimental design or product inquiries, please contact Ascent Research.
